Controversies in design and interpretation of adjuvant clinical trials. - Wikidata - wikimedia - TriplyDB

Controversies in design and interpretation of adjuvant clinical trials.

Controversies in design and interpretation of adjuvant clinical trials.

http://www.wikidata.org/entity/Q37775021

about

Autophagy initiation correlates with the autophagic flux in 3D models of mesothelioma and with patient outcome.Inconsistent selection and definition of local and regional endpoints in breast cancer research.

P2860

Q37189135-87AFC250-372D-46D7-ABAB-499918BB4705 Q38259456-1C870D53-9866-4586-B3EC-9AF5A6B2D5DC

P2860

Controversies in design and interpretation of adjuvant clinical trials.

http://www.wikidata.org/entity/Q37775021

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2010

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Controversies in design and interpretation of adjuvant clinical trials.

@en

Controversies in design and interpretation of adjuvant clinical trials.

@nl

type

label

Controversies in design and interpretation of adjuvant clinical trials.

@en

Controversies in design and interpretation of adjuvant clinical trials.

@nl

prefLabel

Controversies in design and interpretation of adjuvant clinical trials.

@en

Controversies in design and interpretation of adjuvant clinical trials.

@nl

P1433

Q37775021-7ADF50DB-B3BA-4B52-9656-8D7026951B84

P1476

Q37775021-FBE4BE8E-BA47-4FF1-A49F-DE46C61E070A

P2093

Q37775021-3C65B674-9983-4EAC-9AE6-2FB6C8C662E5

P2860

Q37775021-078B3F8D-BDE2-4FAC-99FB-7765D737ED97

Q37775021-0BCA8D07-ACCF-48FD-9594-7CAA0D26E5F1

Q37775021-108EFCEF-F2CA-4EB7-BAFA-17A24C971816

Q37775021-1569A83D-2AE9-4213-850A-62385E6FE983

Q37775021-23A4C33A-10CF-4D7C-9343-C1FD26148077

Q37775021-2EA753FE-431A-4EA4-83DE-A91C4AABC398

Q37775021-433BABC8-52AF-4EC3-8E25-7B603812004B

Q37775021-45FC4F90-F5D7-4DB4-A6F0-5D8C0ED2F305

Q37775021-461D098D-B972-4C66-AE0B-3270BCABD678

Q37775021-51248569-F59F-47C8-A615-5141CB53370E

P304

Q37775021-89BE7346-8144-4B5E-86DE-25F7BE1B07ED

P31

Q37775021-7C3A1936-EB08-4DEE-BB15-5354C77FB8B9

P356

Q37775021-AD281044-87CB-4AAC-A02D-44CD9B96AC1C

P478

Q37775021-BF47EA50-C4E8-4A6F-B38F-6C3BEFE56104

P577

Q37775021-16B38265-1CCC-4BA4-8EF5-3C204F70F4BB

P698

Q37775021-9D7D7E60-5E1C-4BDC-AF4E-6CE19E22381D

P356

07357907.2010.501633

P1433

Cancer Investigation

P1476

Controversies in design and interpretation of adjuvant clinical trials.

@en

P2093

Jack Cuzick

http://www.w3.org/2001/XMLSchema#string

P2860

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009

Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial

Letrozole therapy alone or in sequence with tamoxifen in women with breast cancer

Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer.

Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.

A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer.

American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: status report 2004.

Should aromatase inhibitors be used as initial adjuvant treatment or sequenced after tamoxifen?

Endpoints in adjuvant treatment trials: a systematic review of the literature in colon cancer and proposed definitions for future trials.

Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007.

P304

28-34

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/07357907.2010.501633

http://www.w3.org/2001/XMLSchema#string

P478

28 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

20653405

http://www.w3.org/2001/XMLSchema#string